Vilar E - Search Results

1

Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.

Vilar E, Tabernero J, Casado E, Macarulla T, Ramos FJ, Martinelli E, Saura C. Vilar E, et al. Am J Clin Oncol. 2005 Aug;28(4):424. doi: 10.1097/01.coc.0000162426.79311.a5. Am J Clin Oncol. 2005. PMID: 16062087 No abstract available.

2

Molecular biology of testicular germ cell tumors.

Vilar E, Calvo E, Tabernero J. Vilar E, et al. Clin Transl Oncol. 2006 Dec;8(12):846-50. doi: 10.1007/s12094-006-0147-0. Clin Transl Oncol. 2006. PMID: 17169757 Review.

3

New drug development in digestive neuroendocrine tumors.

Durán I, Salazar R, Casanovas O, Arrazubi V, Vilar E, Siu LL, Yao J, Tabernero J. Durán I, et al. Among authors: vilar e. Ann Oncol. 2007 Aug;18(8):1307-13. doi: 10.1093/annonc/mdm009. Epub 2007 Feb 13. Ann Oncol. 2007. PMID: 17301070 Free article. Review.

4

Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors.

Vilar E, Salazar R, Pérez-García J, Cortes J, Oberg K, Tabernero J. Vilar E, et al. Endocr Relat Cancer. 2007 Jun;14(2):221-32. doi: 10.1677/ERC-06-0074. Endocr Relat Cancer. 2007. PMID: 17639039 Review.

5

Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines.

Vilar E, Scaltriti M, Balmaña J, Saura C, Guzman M, Arribas J, Baselga J, Tabernero J. Vilar E, et al. Br J Cancer. 2008 Nov 18;99(10):1607-12. doi: 10.1038/sj.bjc.6604691. Epub 2008 Oct 21. Br J Cancer. 2008. PMID: 18941461 Free PMC article.

6

A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors.

Vilar E, Grünwald V, Schöffski P, Singer H, Salazar R, Iglesias JL, Casado E, Cullell-Young M, Baselga J, Tabernero J. Vilar E, et al. Invest New Drugs. 2012 Feb;30(1):299-305. doi: 10.1007/s10637-010-9529-9. Epub 2010 Sep 7. Invest New Drugs. 2012. PMID: 20820909 Clinical Trial.

7

Pushing the envelope in the mTOR pathway: the second generation of inhibitors.

Vilar E, Perez-Garcia J, Tabernero J. Vilar E, et al. Mol Cancer Ther. 2011 Mar;10(3):395-403. doi: 10.1158/1535-7163.MCT-10-0905. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216931 Free PMC article. Review.

8

Molecular predictors of response to chemotherapy in colorectal cancer.

Dienstmann R, Vilar E, Tabernero J. Dienstmann R, et al. Among authors: vilar e. Cancer J. 2011 Mar-Apr;17(2):114-26. doi: 10.1097/PPO.0b013e318212f844. Cancer J. 2011. PMID: 21427555 Review.

9

Micromanaging the classification of colon cancer: the role of the microRNAome.

Vilar E, Tabernero J, Gruber SB. Vilar E, et al. Clin Cancer Res. 2011 Dec 1;17(23):7207-9. doi: 10.1158/1078-0432.CCR-11-2440. Epub 2011 Oct 21. Clin Cancer Res. 2011. PMID: 22019515 Free PMC article.

10

Cancer: Pinprick diagnostics.

Vilar E, Tabernero J. Vilar E, et al. Nature. 2012 Jun 27;486(7404):482-3. doi: 10.1038/486482a. Nature. 2012. PMID: 22739312 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters